Predicción y previsión de precio de Freenome, Inc. Common stock (FRNM)FRNMFreenome, Inc. Common stock

Alphio's FRNM stock price prediction model matches the current Freenome, Inc. Common stock tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $13.29 (+1.90%). The 1-week path is $14.01 (+7.44%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Freenome, Inc. is a good buy right now due to its recent FDA approval for a colorectal cancer screening test, which has driven a 5% increase in stock price and indicates strong future revenue potential. The current price is $12.77, significantly below the analyst price target of $21, suggesting a potential upside of 64%. Additionally, the stock has shown a recent 5-day change of +8.68%, indicating positive momentum. However, a risk to consider is the negative net income reported for Q4 2025 at -740568.00 USD, which highlights ongoing financial challenges that could affect performance in the near term.

Freenome, Inc. Common stock (FRNM) last closed at $13.04, gaining +2.52%. These facts feed the 1-day and 1-week FRNM price prediction above.